Cite
HARVARD Citation
Mizugaki, H. et al. (2022). Pharmacokinetic and pharmacogenomic analysis of low-dose afatinib treatment in elderly patients with EGFR mutation-positive non–small cell lung cancer. European journal of cancer. pp. 227-234. [Online].